Cargando…

Molecular profiling and identification of prognostic factors in Chinese patients with small bowel adenocarcinoma

Small bowel adenocarcinoma (SBA) is a rare malignancy with a poor prognosis and limited treatment options. Despite prior studies, molecular characterization of this disease is not well defined, and little is known regarding Chinese SBA patients. In this study, we conducted multigene next‐generation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Hongming, Cheng, Huanqing, Wang, Huina, Ge, Weiting, Yuan, Meiqin, Jiang, Sujing, Wan, Xiangbo, Dong, Ying, Liu, Zhen, Zhao, Rongjie, Fang, Yong, Lou, Feng, Cao, Shanbo, Han, Weidong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586671/ https://www.ncbi.nlm.nih.gov/pubmed/34449929 http://dx.doi.org/10.1111/cas.15119

Ejemplares similares

Comprehensive Analysis of Genomic Alterations in Hepatoid Adenocarcinoma of the Stomach and Identification of Clinically Actionable Alterations
por: Zhao, Rongjie, et al.
Publicado: (2022)

Prognosis and nomogram for predicting postoperative survival of duodenal adenocarcinoma: A retrospective study in China and the SEER database
por: Jiang, Sujing, et al.
Publicado: (2018)

Comparative genomic signatures in young and old Chinese patients with colorectal cancer
por: Wang, Fei, et al.
Publicado: (2021)

Comprehensive Molecular Profiling of Colorectal Cancer With Situs Inversus Totalis by Next-Generation Sequencing
por: Li, Hongsen, et al.
Publicado: (2022)

Molecular and clinical analysis of Chinese patients with anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer
por: Zhou, Xiaoyun, et al.
Publicado: (2019)

Mutation patterns and evolutionary action score of TP53 enable identification of a patient population with poor prognosis in advanced non‐small cell lung cancer
por: Jiang, Wensheng, et al.
Publicado: (2022)

Comprehensive analysis of genomic alterations detected by next-generation sequencing-based tissue and circulating tumor DNA assays in Chinese patients with non-small cell lung cancer
por: Yang, Hua, et al.
Publicado: (2019)

CircUBAP2-mediated competing endogenous RNA network modulates tumorigenesis in pancreatic adenocarcinoma
por: Zhao, Rongjie, et al.
Publicado: (2019)

Comprehensive Molecular Characterization of Chinese Patients with Glioma by Extensive Next-Generation Sequencing Panel Analysis
por: Zeng, Chun, et al.
Publicado: (2021)

Clinical characteristics and programmed cell death ligand-1 expression in adenocarcinoma in situ and minimally invasive adenocarcinoma of lung
por: Yu, Renke, et al.
Publicado: (2017)

The prevalence and prognostic significance of KRAS mutation subtypes in lung adenocarcinomas from Chinese populations
por: Zheng, Difan, et al.
Publicado: (2016)

Analysis of potential genes and pathways associated with the colorectal normal mucosa–adenoma–carcinoma sequence
por: Wu, Zhuoxuan, et al.
Publicado: (2018)

Prognostic Performance of Different Lymph Node Staging Systems in Patients With Small Bowel Neuroendocrine Tumors
por: Jiang, Sujing, et al.
Publicado: (2020)

Mutational pattern off homologous recombination repair (HRR)‐related genes in upper tract urothelial carcinoma
por: Yang, Kaiwei, et al.
Publicado: (2023)

Molecular Identification and Genetic Characterization of Early-Stage Multiple Primary Lung Cancer by Large-Panel Next-Generation Sequencing Analysis
por: Pei, Guotian, et al.
Publicado: (2021)

Integrated Analysis Identifies DPP7 as a Prognostic Biomarker in Colorectal Cancer
por: Zhang, Wei, et al.
Publicado: (2023)

Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study
por: Aparicio, T, et al.
Publicado: (2013)

Natural history and prognostic factors for localised small bowel adenocarcinoma
por: Colina, Andreina, et al.
Publicado: (2020)

Function and prognostic value of basement membrane -related genes in lung adenocarcinoma
por: Zhang, Yurong, et al.
Publicado: (2023)

Germline Mutation Landscape and Associated Clinical Characteristics in Chinese Patients With Renal Cell Carcinoma
por: Kong, Wen, et al.
Publicado: (2021)

Adenocarcinoma of Small Bowel
por: Fadavi, Pedram, et al.
Publicado: (2015)

Immunochemotherapy achieved a complete response for metastatic adenocarcinoma of unknown primary based on gene expression profiling: a case report and review of the literature
por: Sheng, Jin, et al.
Publicado: (2023)

Prognostic factors and treatment outcomes in patients with non-ampullary small bowel adenocarcinoma: Long-term analysis
por: Tian, Jiangfang, et al.
Publicado: (2019)

Small bowel adenocarcinoma: An overview
por: Khosla, Divya, et al.
Publicado: (2022)

Metachronous small bowel adenocarcinoma after rectal adenocarcinoma: A case report
por: Zhen, Ya’nan, et al.
Publicado: (2021)

Unusual metachronous lung adenocarcinomas harboring EGFR L858R/T790M mutations: A case report
por: Pei, Guotian, et al.
Publicado: (2020)

Molecular Landscape of Small Bowel Adenocarcinoma
por: Pandya, Karan, et al.
Publicado: (2022)

Systemic chemotherapy for treatment of advanced small bowel adenocarcinoma with prognostic factor analysis: retrospective study
por: Koo, Dong Hoe, et al.
Publicado: (2011)

Risk and Prognostic Factors for Small Bowel Adenocarcinoma: A Multicenter Retrospective Observational Study in China
por: Wei, Xin, et al.
Publicado: (2022)

The Role of Anti-EGFR Monoclonal Antibody in mCRC Maintenance Therapy
por: Yuan, Meiqin, et al.
Publicado: (2022)

STIM1 Deficiency In Intestinal Epithelium Attenuates Colonic Inflammation and Tumorigenesis by Reducing ER Stress of Goblet Cells
por: Liang, Xiaojing, et al.
Publicado: (2022)

Prognostic Value of Lymph Node Evaluation in Stage II Small Bowel Adenocarcinoma: An Updated Analysis of Surveillance, Epidemiology, and End Results Database
por: Liu, Zhen, et al.
Publicado: (2022)

Prognostic Value of Immune Environment Analysis in Small Bowel Adenocarcinomas with Verified Mutational Landscape and Predisposing Conditions
por: Wirta, Erkki-Ville, et al.
Publicado: (2020)

Development and validation of prognostic nomograms for patients with metastatic small bowel adenocarcinoma: a retrospective cohort study
por: Zhu, Hanlong, et al.
Publicado: (2022)

Adenocarcinoma of the Small Bowel: A Surgical Dilemma
por: Vagholkar, Ketan, et al.
Publicado: (2009)

Anti‐EGFR Therapy in Small Bowel Adenocarcinoma
por: Safyan, Rachael A., et al.
Publicado: (2018)

Persistent Small Bowel Obstruction due to Small Bowel Adenocarcinoma: A Case Report
por: Fleites, Orlando, et al.
Publicado: (2021)

Nivolumab plus regorafenib in patients with small bowel adenocarcinoma: A case report
por: Zhang, Gairong, et al.
Publicado: (2021)

Adenocarcinoma of the Large Bowel
por: Shepherd, J. M., et al.
Publicado: (1971)

Prognostic factors and treatment outcomes in patients with Small Bowel Adenocarcinoma (SBA): The Royal Marsden Hospital (RMH) experience
por: Khan, Khurum, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_khln4dckrlmrb5divr9t3n15ra